Shi Li-Jun, Li Teng-Qi, Xu Xin, Wang Pei-Xu, Li Zhi-Zhuo, Gao Fu-Qiang, Sun Wei
Department of Orthopaedics, Graduate School of Peking Union Medical College, China-Japan Friendship Hospital, Beijing 100029, China.
Zhongguo Gu Shang. 2021 Dec 25;34(12):1158-64. doi: 10.12200/j.issn.1003-0034.2021.12.013.
To explore the clinical efficacy of focused extracorporeal shock wave therapy with centrifugal exercise in the treatment of greater trochanteric pain syndrome.
From September 2017 to June 2019, 53 eligible cases of greater trochanteric pain syndrome were randomly divided into observation group (29 cases) and control group (24 cases). In observation group, there were 8 males and 21 females, aged from 38 to 62 years old with an average of (49.96±6.39) years old; the course of disease ranged from 6 to 13 months with an average of (8.58±1.99) months;treated with focused extracorporeal shock wave therapy with centrifugal exercise. In control group, there were 5 males and 19 females, aged from 39 to 62 years old with an average of (52.79±5.86) years old;the course of disease ranged from 6 to 14 months with an average of (9.04±2.51) months;treated with centrifugal exercise alone. Visual analogue scale (VAS) and hip Harris score were measured before ESWT treatment and at 1, 2, and 6 months to evaluate relieve degree of pain and functional recovery of hip joint, respectively.
At 1 month after treatment, there were no significant differences in VAS, hip Harris score and treatment success rate (all >0.05). At 2 months after treatment, VAS score in observation group (3.20±0.81) was lower than that of control group (3.87±0.61, =0.002), there were no significant differences in hip Harris score score between observation group (81.93±2.43) and control group (82.12±2.34, =0.770), the treatment success rate in observation group (58.62%, 17 / 29) was higher than that of control group (29.16%, 7 / 24) (=0.032). At 6 months after treatment, VAS score in observationgroup (2.24±0.68) was lower than that of control group (3.12±0.53, <0.001), hip Harris score score in observation group(85.10±1.75) was higher than that of control group (83.66±1.78)(=0.005), there were no significant differences in treatment success rate between observation group (82.75%, 24 / 29) and control group (62.50%, 15 / 24)(=0.096).
In treatment of greater trochanteric pain syndrome, focused extracorporeal shock wave therapy with centrifugal exercise could significantly relieve symptoms of lateral hip pain, improve functional recovery of hip joint with good safety. This treatment strategy is worthy of application and promotion in clinical practice.
探讨聚焦体外冲击波联合离心运动疗法治疗大转子疼痛综合征的临床疗效。
选取2017年9月至2019年6月符合条件的53例大转子疼痛综合征患者,随机分为观察组(29例)和对照组(24例)。观察组男8例,女21例,年龄38~62岁,平均(49.96±6.39)岁;病程6~13个月,平均(8.58±1.99)个月,采用聚焦体外冲击波联合离心运动疗法治疗。对照组男5例,女19例,年龄39~62岁,平均(52.79±5.86)岁;病程6~14个月,平均(9.04±2.51)个月,单纯采用离心运动疗法治疗。分别于体外冲击波治疗前及治疗后1、2、6个月测量视觉模拟评分(VAS)和髋关节Harris评分,以评估疼痛缓解程度和髋关节功能恢复情况。
治疗后1个月,两组VAS、髋关节Harris评分及治疗成功率比较,差异均无统计学意义(均P>0.05)。治疗后2个月,观察组VAS评分(3.20±0.81)低于对照组(3.87±0.61,P=0.002),观察组髋关节Harris评分(81.93±2.43)与对照组(82.12±2.34,P=0.770)比较,差异无统计学意义,观察组治疗成功率(58.62%,17/29)高于对照组(29.16%,7/24)(P=0.032)。治疗后6个月,观察组VAS评分(2.24±0.68)低于对照组(3.12±0.53,P<0.001),观察组髋关节Harris评分(85.10±1.75)高于对照组(83.66±1.78)(P=0.005),观察组与对照组治疗成功率比较,差异无统计学意义(P=0.096)。
聚焦体外冲击波联合离心运动疗法治疗大转子疼痛综合征,能显著缓解髋关节外侧疼痛症状,促进髋关节功能恢复,安全性良好,值得临床推广应用。